Answers are grounded in this paper and cite their sources.
Following solid organ transplantation, small precursor populations of polyclonal CD8 + T cells specific for any graft-expressed antigen preferentially expand their high affinity clones. This phenomenon, termed ‘avidity maturation', results in a larger population of CD8 + T cells with increased sensitivity to alloantigen, posing a greater risk for graft rejection. Using a mouse model of minor-mismatched skin transplantation, coupled with the tracking of two skin graft-reactive CD8 + TCR-transgenic (Tg) tracer populations with high and low affinity for the same peptide-major histocompatibility complex (pMHC), we explored the conventional paradigm that CD8 + T cell avidity maturation occurs through T-cell receptor (TCR) affinity-based competition for cognate antigen. Our data revealed ‘interclonal CD8-CD8 help', whereby lower/intermediate affinity clones help drive the preferential expansion of their higher affinity counterparts in an IL-2/CD25-dependent manner. Consequently, the CD8-helped high affinity clones exhibit greater expansion and develop augmented effector functions in the presence of their low affinity counterparts, correlating with more severe graft damage. Finally, interclonal CD8-CD8 help was suppressed by costimulation blockade treatment. Thus, high affinity CD8 + T cells can leverage help from low affinity CD8 + T cells of identical specificity to promote graft rejection. Suppressing provision of interclonal CD8-CD8 help may be important to improve transplant outcomes.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: